RBBN
Overvalued by 116.4% based on the discounted cash flow analysis.
Market cap | $722.49 Million |
---|---|
Enterprise Value | $858.89 Million |
Dividend Yield | $- (-) |
Earnings per Share | $-0.31 |
Beta | 1.34 |
Outstanding Shares | 176,237,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -16.2 |
---|---|
PEG | 47.61 |
Price to Sales | 1.04 |
Price to Book Ratio | 4.16 |
Enterprise Value to Revenue | 0.99 |
Enterprise Value to EBIT | -17.03 |
Enterprise Value to Net Income | -20 |
Total Debt to Enterprise | 0.23 |
Debt to Equity | 0.53 |
No data
No data